Enzalutamide
Pfizer,Astellas
['brca', 'crpc']
dr. david olmos on outcomes in first-line mcrpc based on brca/hrr status #asco23 #urology #urologist 
The Leading News Source for Urologists - https://t.co/hDKngB4IyE
Expert clinical analysis. Practice advice. Policy perspectives.